Department of Internal Medicine, University of Tsukuba Institute of Clinical Medicine, Ibaraki, Japan.
Diabet Med. 2012 Oct;29(10):1285-90. doi: 10.1111/j.1464-5491.2012.03667.x.
We aimed to characterize the association of insulin resistance, impaired insulin secretion and β-cell dysfunction in relation to HbA(1c) levels in a non-diabetic range in Japanese individuals without clinically diagnosed diabetes.
This cross-sectional study included 1444 individuals without a history of outpatient treatment of diabetes or use of insulin or oral hypoglycaemic agents. The homeostasis model assessment of insulin resistance and beta-cell function, insulinogenic index, Matsuda index and disposition index were calculated using data from 75-g oral glucose tolerance tests and compared across quintile (Q) categories of HbA(1c) levels.
Fasting plasma glucose and 30-min and 60-min plasma glucose (PG) levels were significantly higher when HbA(1c) exceeded 36 mmol/mol (5.4%). A HbA(1c) concentration of 36-37 mmol/mol (5.4-5.5%) (Q3) was significantly associated with a 15% lower homeostasis model assessment of β-cell function value and 31% lower insulinogenic index value compared with HbA(1c) ≤ 32 mmol/mol (≤ 5.1%) (Q1) (P <0.01). Further, a HbA(1c) concentration of 38-40 mmol/mol (5.6-5.8%) (Q4) was associated with 17% (P <0.01) and 24% (P <0.05) reductions in those indexes, respectively. However, the homeostasis model assessment of insulin resistance was not significantly elevated and the Matsuda index was not significantly lower unless HbA(1c) exceeded 41 mmol/mol (5.9%). Individuals with HbA(1c) ≥ 41 mmol/mol (≥ 5.9%) (Q5) had a 69% lower disposition index than those with a HbA(1c) concentration of ≤ 32 mmol/mol (≤ 5.1%) (Q1).
Elevated HbA(1c) levels ≥ 41 mmol/mol (≥ 5.9%) were associated with substantial reductions in insulin secretion, insulin sensitivity and β-cell dysfunction in Japanese individuals not treated for diabetes. High normal HbA(1c) levels of 36-40 mmol/mol (5.4-5.8%) were also associated with impaired insulin secretion without marked insulin resistance in Japanese individuals.
我们旨在描述在日本非糖尿病个体中,与 HbA1c 水平在非糖尿病范围内相关的胰岛素抵抗、胰岛素分泌受损和β细胞功能障碍的关联。
这项横断面研究纳入了 1444 名无糖尿病门诊治疗或使用胰岛素或口服降糖药史的个体。使用 75g 口服葡萄糖耐量试验的数据计算了胰岛素抵抗和β细胞功能的稳态模型评估、胰岛素原指数、Matsuda 指数和处置指数,并比较了 HbA1c 水平五分位数(Q)类别。
当 HbA1c 超过 36mmol/mol(5.4%)时,空腹血浆葡萄糖和 30 分钟及 60 分钟血浆葡萄糖(PG)水平显著升高。与 HbA1c≤32mmol/mol(≤5.1%)(Q1)相比,HbA1c 浓度为 36-37mmol/mol(5.4-5.5%)(Q3)时,胰岛素原指数降低 15%,胰岛素分泌指数降低 31%(P<0.01)。此外,HbA1c 浓度为 38-40mmol/mol(5.6-5.8%)(Q4)时,这两个指数分别降低 17%(P<0.01)和 24%(P<0.05)。然而,除非 HbA1c 超过 41mmol/mol(5.9%),否则胰岛素抵抗的稳态模型评估并没有显著升高,Matsuda 指数也没有显著降低。HbA1c≥41mmol/mol(≥5.9%)(Q5)的个体与 HbA1c 浓度≤32mmol/mol(≤5.1%)(Q1)的个体相比,处置指数降低了 69%。
在未经糖尿病治疗的日本个体中,HbA1c 水平升高≥41mmol/mol(≥5.9%)与胰岛素分泌、胰岛素敏感性和β细胞功能障碍显著降低有关。HbA1c 处于较高的正常范围(36-40mmol/mol,5.4-5.8%)也与日本个体的胰岛素分泌受损而无明显胰岛素抵抗有关。